Roivant Sciences, Director of Immunovant IMVT, has filed 3 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $350M. The latest trade was on 25/12/12.

Roivant Sciences

Director

Company

Immunovant IMVT

First filing

23/10/04

Trades

4 trades

Buys / sales

3 / 0

12-month net buying

$350M

Last trade

25/12/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
ImmunovantIMVT	Open-market buy	25/12/12	25/12/12	16,666,666 sh	$21.00	$349,999,986	+17.2%
ImmunovantIMVT	Open-market buy	25/01/13	25/01/15	16,845,010 sh	$20.00	$336,900,200	+21.1%
ImmunovantIMVT	Open-market buy	23/10/02	23/10/04	1,526,316 sh	$38.00	$58,000,008	+1.9%